Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil υδροχλωρική - Πρωτοπλαστικά νεοπλάσματα - Αντινεοπλασματικοί παράγοντες - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ΦΑΡΜΕΞ Α.Ε. - ΤΡΙΦΛΟΥΡΙΔΙΝΗ - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 1% - 0000070008 - trifluridine - 10.000000 mg - trifluridine

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

novartis hellas aebe - ΤΟΜΕΑΣ ciba vision - trifluridine - ΟΦΘΑΛΜΙΚΗ ΑΛΟΙΦΗ - 1% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

novartis hellas aebe - ΤΟΜΕΑΣ ciba vision - trifluridine - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 1% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ΙΦΕΤ ΑΕ - ΤΡΙΦΛΟΥΡΙΔΙΝΗ - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 1% - 0000070008 - trifluridine - 0.000000